Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

MORF

Morphic (MORF)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MORF
DataOraFonteTitoloSimboloCompagnia
06/06/202401:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MORFMorphic Holding Inc
05/06/202422:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MORFMorphic Holding Inc
31/05/202414:00GlobeNewswire Inc.Morphic to Participate in Jefferies Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
21/05/202414:00GlobeNewswire Inc.Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking CellsNASDAQ:MORFMorphic Holding Inc
09/05/202422:05GlobeNewswire Inc.Morphic to Participate in RBC Capital Markets Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
25/04/202413:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024NASDAQ:MORFMorphic Holding Inc
19/03/202413:00GlobeNewswire Inc.Morphic Appoints Dr. Simon Cooper as Chief Medical OfficerNASDAQ:MORFMorphic Holding Inc
05/03/202422:05GlobeNewswire Inc.Morphic to Participate in March Investor ConferencesNASDAQ:MORFMorphic Holding Inc
22/02/202413:46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MORFMorphic Holding Inc
22/02/202413:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MORFMorphic Holding Inc
22/02/202413:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023NASDAQ:MORFMorphic Holding Inc
03/01/202422:05GlobeNewswire Inc.Morphic to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
10/11/202314:00GlobeNewswire Inc.Morphic to Present at November Investor ConferencesNASDAQ:MORFMorphic Holding Inc
03/11/202312:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MORFMorphic Holding Inc
03/11/202312:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023NASDAQ:MORFMorphic Holding Inc
09/10/202314:00GlobeNewswire Inc.Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data SetNASDAQ:MORFMorphic Holding Inc
26/09/202322:10GlobeNewswire Inc.Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of AbsenceNASDAQ:MORFMorphic Holding Inc
22/09/202323:30GlobeNewswire Inc.Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023NASDAQ:MORFMorphic Holding Inc
07/09/202322:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MORFMorphic Holding Inc
29/08/202314:00GlobeNewswire Inc.Morphic Announces Participation in 2023 Wells Fargo Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
09/08/202322:05GlobeNewswire Inc.Morphic to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:MORFMorphic Holding Inc
03/08/202313:05GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023NASDAQ:MORFMorphic Holding Inc
24/06/202301:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MORFMorphic Holding Inc
06/06/202322:05GlobeNewswire Inc.Morphic to Present at the Jefferies Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
02/06/202322:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MORFMorphic Holding Inc
12/05/202314:30GlobeNewswire Inc.Morphic to Present at 2023 RBC Capital Markets Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
11/05/202314:00GlobeNewswire Inc.Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative ColitisNASDAQ:MORFMorphic Holding Inc
05/05/202316:30GlobeNewswire Inc.Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:MORFMorphic Holding Inc
04/05/202312:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MORFMorphic Holding Inc
03/05/202306:13GlobeNewswire Inc.Morphic Therapeutic Announces Pricing of $240.0 Million Public OfferingNASDAQ:MORFMorphic Holding Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MORF
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network